Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

E. Sands, Bruce; G. Feagan, Brian; Rutgeerts, Paul; Colombel, Jean‐Frédéric; J. Sandborn, William; Sy, Richmond; D’Haens, Geert; Ben‐Horin, Shomron; Xu, Jing; Rosario, Maria; H. Fox, Irving; Parikh, Asit; Milch, Catherine; B. Hanauer, Stephen

doi:10.1053/j.gastro.2014.05.008

Public

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

Published in Gastroenterology • May 21, 2014

Authors:

Bruce E. Sands

Brian G. Feagan

Paul Rutgeerts

Abstract

BACKGROUND & AIMS: There is an increasing need for new treatments for patients with Crohn's disease (CD) in whom previous therapy with tumor necrosis factor (TNF) antagonists has failed. We performed a placebo-controlled, phase 3, double-blind trial to evaluate the efficacy and safety of vedolizumab...

Subject

Vedolizumab

Medicine

Crohn's disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!